James P Corsetti

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
    PLoS ONE 8:e68920. 2013
  2. pmc Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    PLoS ONE 7:e39110. 2012
  3. doi request reprint Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Metabolism 61:996-1002. 2012
  4. doi request reprint Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Thromb Haemost 106:1170-8. 2011
  5. doi request reprint Glycerol as a reference material for fecal fat quantitation using low-resolution time domain ¹H NMR spectroscopy
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Clin Biochem 44:1352-4. 2011
  6. pmc Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642, USA
    Arterioscler Thromb Vasc Biol 30:1657-64. 2010
  7. doi request reprint Inflammation reduces HDL protection against primary cardiac risk
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Eur J Clin Invest 40:483-9. 2010
  8. doi request reprint Lp(a) and risk of recurrent cardiac events in obese postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Obesity (Silver Spring) 16:2717-22. 2008
  9. ncbi request reprint Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Arterioscler Thromb Vasc Biol 28:548-54. 2008
  10. ncbi request reprint High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Clin Chem 52:1331-8. 2006

Detail Information

Publications20

  1. pmc Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
    PLoS ONE 8:e68920. 2013
    ....
  2. pmc Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    PLoS ONE 7:e39110. 2012
    ..To assess whether apolipoprotein A-II (apoA-II) plays a role in apoE-associated risk in the two female groups...
  3. doi request reprint Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Metabolism 61:996-1002. 2012
    ..Future studies should be oriented toward investigations of apoE as related to multiplicity of HDL functionality and toward assessment of potential roles for apoE in dysfunctional transformation of HDL...
  4. doi request reprint Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Thromb Haemost 106:1170-8. 2011
    ..Further studies should focus on additional effects of vascular inflammatory processes on anti-atherogenic functionality of HDL particles...
  5. doi request reprint Glycerol as a reference material for fecal fat quantitation using low-resolution time domain ¹H NMR spectroscopy
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Clin Biochem 44:1352-4. 2011
    ..To assess glycerol as reference material for low-resolution time-domain (1)H NMR analysis of fecal fat...
  6. pmc Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642, USA
    Arterioscler Thromb Vasc Biol 30:1657-64. 2010
    ..To investigate the roles of inflammation and a cholesteryl ester transfer protein (CETP) polymorphism potentially related to recent findings demonstrating coronary risk with increasing high-density lipoprotein cholesterol (HDL-C) level...
  7. doi request reprint Inflammation reduces HDL protection against primary cardiac risk
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Eur J Clin Invest 40:483-9. 2010
    ..We investigated whether a similar high-risk subgroup might exist for incident cardiovascular disease...
  8. doi request reprint Lp(a) and risk of recurrent cardiac events in obese postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Obesity (Silver Spring) 16:2717-22. 2008
    ..These findings suggest close monitoring and consideration of weight reduction for obese postinfarction patients with elevated Lp(a) levels...
  9. ncbi request reprint Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Arterioscler Thromb Vasc Biol 28:548-54. 2008
    ..The aim of this study was to assess such risk as a function of 37 atherosclerosis-associated genetic polymorphisms and 17 blood marker variables...
  10. ncbi request reprint High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Clin Chem 52:1331-8. 2006
    ....
  11. ncbi request reprint Glycoprotein Ibalpha polymorphism T145M, elevated lipoprotein-associated phospholipase A2, and hypertriglyceridemia predict risk for recurrent coronary events in diabetic postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Diabetes 56:1429-35. 2007
    ....
  12. doi request reprint LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA james
    Atherosclerosis 214:373-6. 2011
    ....
  13. ncbi request reprint Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    Atherosclerosis 187:191-7. 2006
    ..023). We conclude that in non-diabetic postinfarction patients, elevated HDL is predictive of risk of recurrent coronary events within a subgroup of patients characterized by simultaneous elevations in serum CRP and total cholesterol...
  14. ncbi request reprint Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Atherosclerosis 183:293-300. 2005
    ..Finding different within-subgroup predictors of risk underscores the notion of context-dependent risk, an observation that may be relevant for determining optimal use of emerging risk factors...
  15. ncbi request reprint Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers
    Ilan Goldenberg
    Cardiology Units of the Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Ann Noninvasive Electrocardiol 12:364-74. 2007
    ..We hypothesized that susceptibility to early onset myocardial infarction (MI) among cigarette smokers may be related to the presence of TaqIB polymorphism in the CETP gene...
  16. ncbi request reprint NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Atherosclerosis 196:461-8. 2008
    ..34-7.35 and 0.0084). We conclude that oxidative stress plays a significant role in establishment of risk for recurrent coronary events in a high-risk subgroup of postinfarction patients defined by inflammation and hypercholesterolemia...
  17. ncbi request reprint Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients
    James P Corsetti
    Department of Pathology and Laboratory Medicine, School of Medicine and Dentistry, University of Rochester, P O Box 626, 601 Elmwood Avenue, Rochester, NY, USA
    Atherosclerosis 171:351-8. 2003
    ....
  18. ncbi request reprint Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome
    James P Corsetti
    Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Box 626, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Atherosclerosis 177:367-73. 2004
    ....
  19. pmc Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation
    Nhat Tu Le
    School of Medicine and Dentistry, Aab Cardiovascular Research Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box CVRI, Rochester, NY 14642, USA
    Int J Inflam 2012:678190. 2012
    ....
  20. ncbi request reprint Chronic kidney disease prevalence and rate of diagnosis
    Timothy P Ryan
    Department of Community and Preventive Medicine, Division of Epidemiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Am J Med 120:981-6. 2007
    ....